Bluebird Bio, Inc.
Records under this name other than patents Bluebird Bio, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,280,435 | Gene Therapy Methods now held by Genetix Biotherapeutics Inc. In force · High confidence | In force | High confidence | |
| US 9,783,822 | Gene Therapy Methods now held by Genetix Biotherapeutics Inc. In force · High confidence | In force | High confidence | |
| US 8,858,928 | Gene Therapy Vectors for Adrenoleukodystrophy and Adrenomyeloneuropathy now held by Genetix Biotherapeutics Inc. In force · High confidence | In force | High confidence | |
| US 9,061,031 | Gene Therapy Vectors for Adrenoleukodystrophy and Adrenomyeloneuropathy now held by Genetix Biotherapeutics Inc. In force · Medium confidence | In force | Medium confidence | |
| US 9,789,139 | Gene Therapy Vectors for Adrenoleukodystrophy and Adrenomyeloneuropathy now held by Genetix Biotherapeutics Inc. In force · Medium confidence | In force | Medium confidence | |
| US 9,988,644 | Compounds for Improved Viral Transduction now held by Genetix Biotherapeutics Inc. In force · High confidence | In force | High confidence | |
| US 10,501,759 | Compounds for Improved Viral Transduction now held by Genetix Biotherapeutics Inc. In force · Medium confidence | In force | Medium confidence | |
| US 10,907,177 | Compounds for Improved Viral Transduction now held by Genetix Biotherapeutics Inc. In force · Medium confidence | In force | Medium confidence | |
| US 11,834,668 | Compounds for Improved Viral Transduction now held by Genetix Biotherapeutics Inc. In force · Medium confidence | In force | Medium confidence | |
| US 10,196,444 | Multipartite Signaling Proteins and Uses Thereof now held by Regeneron Pharmaceuticals, Inc. In force · High confidence | In force | High confidence |